Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01391533 |
Title | Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors |
Acronym | SARMET |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Sanofi |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | ITA | FRA | ESP |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Investigational Site Number 840001 | Boston | Massachusetts | 02114 | United States | Details | |
Investigational Site Number 250002 | Dijon | 21079 | France | Details | ||
Investigational Site Number 250001 | Villejuif | 94805 | France | Details | ||
Investigational Site Number 380004 | Bologna | 40138 | Italy | Details | ||
Investigational Site Number 380002 | Milano | 20133 | Italy | Details | ||
Investigational Site Number 380001 | Milano | 20141 | Italy | Details | ||
Investigational Site Number 724001 | Barcelona | 08035 | Spain | Details | ||
Investigational Site Number 724003 | Madrid | 28040 | Spain | Details |